Practice Patterns About Management of Allergic Rhinitis: Indian HCP KAP Experience in 2024 and Preference of Fexofenadine and Montelukast Dr. Kamal Kant Kohli29 Oct 2024 10:00 AM ISTAllergic Rhinitis (AR) is the most common immune-mediated inflammatory condition affecting the nasal mucosa (1) triggered by the production of IgE...
Allergic Rhinitis and Co-morbid Asthma: All Clinician Needs to Know and Consideration of Fexofenadine and Montelukast Combination Dr. Kamal Kant Kohli6 May 2024 11:30 AM ISTAllergic rhinitis (AR), a prevalent non-infectious disease condition; is an IgE-mediated response to allergens, causing symptoms like sneezing,...
Indian Guidelines Review on Allergic Rhinitis and Scope for Use of Fexofenadine and Montelukast Combination Dr. Kamal Kant Kohli22 Jan 2024 11:00 AM ISTAllergic Rhinitis and Its Burden in India: Allergic rhinitis (AR) is a common inflammatory condition that affects the nasal mucosa and is...
Allergens in India and its Avoidance: Review through Indian Guidelines and Role of Fexofenadine-Montelukast Combination Dr. Kamal Kant Kohli4 Dec 2023 12:13 PM ISTAllergic rhinitis is one of the most common allergic diseases, which appears to increase in India. Risk factors, diagnosis, and AR management vary...
Allergic Rhinitis: Latest Practice Insights and Treatment Approach Dr. Kamal Kant Kohli3 Nov 2023 11:13 AM ISTUnderstanding Allergic Rhinitis(AR)Rhinitis is generally defined as inflammation of the nasal mucosa. Allergic rhinitis (AR) is a disease that affects...
Allergic Rhinitis-Phenotypes, Challenges, Therapeutic Approach and Role of Montelukast Fexofenadine Combination Dr. Kamal Kant Kohli30 Jun 2023 11:45 AM ISTAtopic diseases are becoming increasingly prevalent worldwide, and allergic rhinitis (AR), an IgE-mediated inflammatory disease, is one among them....
Managing Atopic Diseases across Age Group Dr. Kamal Kant Kohli27 Feb 2023 11:30 AM ISTAtopy is a genetic tendency to produce high IgE antibodies in response to common allergens, which increases the risk of developing atopic illnesses...
United Airway Disease and Clinical Applicability of Montelukast Fexofenadine Combination: Review Dr. Kamal Kant Kohli20 Oct 2022 12:30 PM ISTRecent epidemiological, pathophysiological, and clinical scientific evidence has identified a relationship between upper and lower respiratory...
Respiratory Allergies in India and Clinical Review of Montelukast Fexofenadine Combination in its Management Dr. Kamal Kant Kohli24 Sept 2022 11:57 AM ISTAllergic respiratory diseases (ARDs) are caused by the production of IgE antibodies to airborne allergens, causing various clinical manifestations in...
Allergic Rhinitis in Children: Practitioners Update and Consideration for Use of Intranasal Fluticasone Based Therapies Dr. Kamal Kant Kohli23 Aug 2022 12:45 PM ISTAllergic rhinitis (AR), an inflammatory disease caused by an IgE-mediated immune response to inhaled allergens, is a frequently occurring childhood...
